(Q39176115)

English

Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.

scientific article published on 23 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

inflammatory bowel diseases

0 references

Miranda C Lomer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Alexis C Prince

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Clio E Myers

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Triona Joyce

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Peter Irving

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kevin Whelan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1129-1136

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Guidelines for the management of inflammatory bowel disease in adults

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Is there any food I can eat? Living with inflammatory bowel disease and/or irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Survey of UK and New Zealand gastroenterologists' practice regarding dietary advice and food exclusion in irritable bowel syndrome and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Mechanisms and efficacy of dietary FODMAP restriction in IBS.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Design of treatment trials for functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Stool form scale as a useful guide to intestinal transit time

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Peripheral factors in the pathophysiology of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Prebiotic effects: metabolic and health benefits

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Seeking control through the determination of diet: a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000708

21 January 2018

Identifiers

10.1097/MIB.0000000000000708

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914438%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39176115&oldid=1636210064"